Joel Magnusson

Senior Associate
  • Stockholm
  • Languages:
    Swedish, English

Education

  • Lund University, LL.M, 2018
  • University of Vienna, 2017

Experience

  • Legal Secondee, EQT, 2022
  • Associate, Setterwalls Advokatbyrå, 2018-2019

Mandates

Mandate October 26, 2022

Vinge has advised Azelio in connection with its rights issue

Vinge has advised Azelio AB (publ) on a fully guaranteed rights issue, which will provide Azelio wit…

Mandate October 18, 2022

Vinge has advised Xspray Pharma in connection with share issue

Vinge has advised Xspray Pharma, a pharmaceutical company with several product candidates in clinica…

Mandate December 20, 2021

Vinge advises SBB on mandatory offer for Amasten

Vinge advises Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) in connection with its public offer…

Mandate December 13, 2021

Vinge advises in conjunction with sale of shares in Embellence Group

Vinge has advised Litorina CoInvest 1 AB in conjunction with the sale of 10.5 percent of the shares…

Mandate December 09, 2021

Vinge has advised Tobii in connection with the listing of Tobii Dynavox

Vinge has advised Tobii and Tobii Dynavox in connection with the distribution of the shares in Tobii…

Mandate December 01, 2021

Vinge advises Cell Impact in connection with its fully guaranteed rights issue of SEK 349 million

Vinge advises Cell Impact AB (publ) in connection with a fully guaranteed rights issue which will pr…

Mandate November 24, 2021

Vinge has advised SBB in connection with a directed share issue

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (”SBB”) in connection with a directed share is…

Mandate November 19, 2021

Vinge has advised SBB in connection with the sale of properties to a company co-owned with Kåpan

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (”SBB”) in connection with the sale of propert…

Mandate November 08, 2021

Vinge has advised Tobii AB (publ) in connection with a directed share issue

Vinge has advised Tobii AB in connection with a directed share issue whereby the company receives ap…

Mandate November 08, 2021

Vinge has advised Xpray Pharma in connection with share issue

Vinge has advised Xspray Pharma, a pharmaceutical company with several product candidates in clinica…

Mandate October 13, 2021

Vinge advises Funnel in conjunction with pre-IPO financing

Vinge has advised Funnel and its shareholders in conjunction with a capital procurement of USD 66 mi…

Mandate September 03, 2021

Vinge has advised SBB in connection with its repurchase of mandatory convertible notes

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (”SBB”) in connection with its repurchase of s…

Mandate June 08, 2021

Vinge advises Sleep Cycle AB (publ) in connection with the listing on Nasdaq Stockholm

Vinge advises Sleep Cycle AB (publ) (“Sleep Cycle” or the “Company”) in connection with the listing…

Mandate May 28, 2021

Vinge has assisted Peab in connection with a transaction with SkiStar

Vinge has assisted Peab in connection with a transaction with Skistar, whereby Peab and SkiStar deep…

Mandate April 28, 2021

Vinge advised Creades in connection with a directed share issue

Vinge advised Creades AB (publ) in connection with a directed share issue of approximately SEK 1 bil…

Mandate March 26, 2021

Vinge advises Embellence Group AB (publ) in connection with the listing on Nasdaq First North Premier Growth Market

Vinge advises Embellence Group AB (publ) (“Embellence Group”) in connection with the listing on Nasd…

Mandate February 10, 2021

Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue

Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue, whereby…

Mandate January 26, 2021

Vinge has advised EQT in connection with the combination with Exeter Property Group

Vinge has advised EQT in connection with the signing of a combination with Exeter Property Group, a…

Mandate December 11, 2020

Vinge has advised Peab in connection with the listing of Annehem Fastigheter

Vinge has advised Peab and Annehem Fastigheter in connection with the distribution of the shares in…

Mandate October 23, 2020

Vinge advises Xspray Pharma in connection with a directed share issue

Vinge has advised the pharmaceutical development company Xspray Pharma in connection with a directed…

Mandate October 09, 2020

Vinge advises Cell Impact AB (publ) in connection with a directed share issue

Vinge has advised Cell Impact AB (publ) in connection with a directed share issue, whereby Cell Impa…

Mandate October 07, 2020

Vinge advises G-Loot in its half a billion SEK financing round

Vinge has advised the esports company G-Loot Global Esports AB (publ) in connection with its financi…

Mandate June 18, 2020

Vinge advises Bergs Timber in connection with transfer of Berg’s Swedish sawmill business

Vinge has advised Bergs Timber AB (publ) in connection with the transfer of the sawmills in Orrefors…

Mandate June 10, 2020

Vinge advises VNV Global in relation to the groups change of domicile from Bermuda to Sweden. 

Vinge has advised VNV Global in connection with the process of changing the group’s domicile from Be…

Mandate May 06, 2020

Vinge has advised Equinor ASA in connection with a sale of shares in Lundin Energy

Vinge has advised Equinor ASA in connection with a sale of shares in Lundin Energy AB (publ) through…

Mandate April 01, 2020

Vinge advises Xspray Pharma in connection with its listing on Nasdaq Stockholm

Vinge advises Xspray Pharma AB (publ) in connection with its list change from Nasdaq First North Gro…

Mandate December 10, 2019

Vinge advises Xspray Pharma in connection with a directed share issue

Vinge has advised the pharmaceutical development company Xspray Pharma in connection with a directed…

Mandate September 24, 2019

Vinge has advised EQT AB (publ) in connection with the listing on Nasdaq Stockholm

Vinge has advised EQT AB (publ) (“EQT”) in connection with the offering and listing on Nasdaq Stockh…